204 related articles for article (PubMed ID: 18808306)
1. Statins: under investigation for increasing bone mineral density and augmenting fracture healing.
Tang QO; Tran GT; Gamie Z; Graham S; Tsialogiannis E; Tsiridis E; Linder T; Tsiridis E
Expert Opin Investig Drugs; 2008 Oct; 17(10):1435-63. PubMed ID: 18808306
[TBL] [Abstract][Full Text] [Related]
2. Update on statins: hope for osteoporotic fracture healing treatment.
Ibrahim N'; Mohamed N; Shuid AN
Curr Drug Targets; 2013 Dec; 14(13):1524-32. PubMed ID: 23876090
[TBL] [Abstract][Full Text] [Related]
3. Effect of statins on bone mineral density and bone histomorphometry in rodents.
Maritz FJ; Conradie MM; Hulley PA; Gopal R; Hough S
Arterioscler Thromb Vasc Biol; 2001 Oct; 21(10):1636-41. PubMed ID: 11597938
[TBL] [Abstract][Full Text] [Related]
4. The role of statins in the differentiation and function of bone cells.
Chamani S; Liberale L; Mobasheri L; Montecucco F; Al-Rasadi K; Jamialahmadi T; Sahebkar A
Eur J Clin Invest; 2021 Jul; 51(7):e13534. PubMed ID: 33656763
[TBL] [Abstract][Full Text] [Related]
5. The ability of statins to protect low density lipoprotein from oxidation in hypercholesterolemic patients.
Thallinger C; Urbauer E; Lackner E; Graselli U; Kostner K; Wolzt M; Joukhadar C
Int J Clin Pharmacol Ther; 2005 Dec; 43(12):551-7. PubMed ID: 16372516
[TBL] [Abstract][Full Text] [Related]
6. Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
Eslami L; Merat S; Malekzadeh R; Nasseri-Moghaddam S; Aramin H
Cochrane Database Syst Rev; 2013 Dec; (12):CD008623. PubMed ID: 24374462
[TBL] [Abstract][Full Text] [Related]
7. Pleiotropic effects of statins in atherosclerosis and diabetes.
Bellosta S; Ferri N; Arnaboldi L; Bernini F; Paoletti R; Corsini A
Diabetes Care; 2000 Apr; 23 Suppl 2():B72-8. PubMed ID: 10860194
[TBL] [Abstract][Full Text] [Related]
8. Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention.
Zhou Z; Rahme E; Pilote L
Am Heart J; 2006 Feb; 151(2):273-81. PubMed ID: 16442888
[TBL] [Abstract][Full Text] [Related]
9. Statins and osteoporosis: new role for old drugs.
Jadhav SB; Jain GK
J Pharm Pharmacol; 2006 Jan; 58(1):3-18. PubMed ID: 16393459
[TBL] [Abstract][Full Text] [Related]
10. Statins and bone morphogenetic proteins: new pathways in bone formation.
Edwards CJ
Ann Acad Med Singap; 2002 Mar; 31(2):245-7. PubMed ID: 11957568
[TBL] [Abstract][Full Text] [Related]
11. Statins and bone metabolism.
Horiuchi N; Maeda T
Oral Dis; 2006 Mar; 12(2):85-101. PubMed ID: 16476028
[TBL] [Abstract][Full Text] [Related]
12. HMG-CoA reductase inhibitors in osteoporosis: do they reduce the risk of fracture?
Schlienger RG; Meier CR
Drugs Aging; 2003; 20(5):321-36. PubMed ID: 12696993
[TBL] [Abstract][Full Text] [Related]
13. Comparison of statins in hypertriglyceridemia.
Stein EA; Lane M; Laskarzewski P
Am J Cardiol; 1998 Feb; 81(4A):66B-69B. PubMed ID: 9526817
[TBL] [Abstract][Full Text] [Related]
14. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
15. Statins have additive effects to vertebral bone mineral density in combination with risedronate in hypercholesterolemic postmenopausal women.
Tanriverdi HA; Barut A; Sarikaya S
Eur J Obstet Gynecol Reprod Biol; 2005 May; 120(1):63-8. PubMed ID: 15866088
[TBL] [Abstract][Full Text] [Related]
16. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase the binding activity and nuclear level of Oct-1 in mononuclear cells.
Ortego M; Hernández AG; Bustos C; Blanco-Colio LM; Hernández-Presa MA; Tuñón J; Egido J
Eur J Pharmacol; 2002 Jul; 448(2-3):113-21. PubMed ID: 12144930
[TBL] [Abstract][Full Text] [Related]
17. Combination of statins and hormone replacement therapy in postmenopausal women is associated with increased bone mineral density.
De Leo V; Morgante G; la Marca A; Lanzetta D; Cobellis L; Petraglia F
Gynecol Endocrinol; 2003 Aug; 17(4):329-32. PubMed ID: 14503978
[TBL] [Abstract][Full Text] [Related]
18. [Atherosclerosis in light of the evidence from large statin trials].
Cortese C; Bernardini S; Motti C
Ann Ital Med Int; 2000; 15(1):103-7. PubMed ID: 10842899
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the efficacies of five different statins on inhibition of human saphenous vein smooth muscle cell proliferation and invasion.
Turner NA; Midgley L; O'Regan DJ; Porter KE
J Cardiovasc Pharmacol; 2007 Oct; 50(4):458-61. PubMed ID: 18049315
[TBL] [Abstract][Full Text] [Related]
20. Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells.
Mulhaupt F; Matter CM; Kwak BR; Pelli G; Veillard NR; Burger F; Graber P; Lüscher TF; Mach F
Cardiovasc Res; 2003 Sep; 59(3):755-66. PubMed ID: 14499877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
